| dbo:abstract
|
- Norbert W. Bischofberger (* 10. Jänner 1956 in Mellau) ist ein österreichischer Biochemiker. Er ist der Entwickler des Influenza-Therapeutikums Tamiflu sowie weiterer Medikamente gegen andere Infektionskrankheiten, wie beispielsweise das HIV-Therapeutikum Viread oder Sovaldi, ein Medikament gegen Hepatitis C. (de)
- Dr. Norbert Bischofberger (born 10 January 1956 in Mellau, Austria) is an Austrian scientist and one of the inventors of the antiviral drug Tamiflu generically known as oseltamivir, which is, as of 2009, the only oral medication on the market to treat influenza A and B as well as the 2009 Pandemic H1N1 (swine flu), the spread of which caused an ongoing pandemic in 2009. Bischofberger was the Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a biopharmaceutical company specializing in antivirals. (en)
|
| dbo:academicAdvisor
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:knownFor
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 6360 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:academicAdvisors
| |
| dbp:birthDate
| |
| dbp:birthPlace
| |
| dbp:doctoralAdvisor
| |
| dbp:education
| |
| dbp:knownFor
| |
| dbp:name
|
- Norbert Bischofberger (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| gold:hypernym
| |
| schema:sameAs
| |
| rdf:type
| |
| rdfs:comment
|
- Norbert W. Bischofberger (* 10. Jänner 1956 in Mellau) ist ein österreichischer Biochemiker. Er ist der Entwickler des Influenza-Therapeutikums Tamiflu sowie weiterer Medikamente gegen andere Infektionskrankheiten, wie beispielsweise das HIV-Therapeutikum Viread oder Sovaldi, ein Medikament gegen Hepatitis C. (de)
- Dr. Norbert Bischofberger (born 10 January 1956 in Mellau, Austria) is an Austrian scientist and one of the inventors of the antiviral drug Tamiflu generically known as oseltamivir, which is, as of 2009, the only oral medication on the market to treat influenza A and B as well as the 2009 Pandemic H1N1 (swine flu), the spread of which caused an ongoing pandemic in 2009. Bischofberger was the Executive Vice President, Research and Development and Chief Scientific Officer at Gilead Sciences, a biopharmaceutical company specializing in antivirals. (en)
|
| rdfs:label
|
- Norbert Bischofberger (Biochemiker) (de)
- Norbert Bischofberger (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Norbert Bischofberger (en)
|
| is dbo:wikiPageDisambiguates
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
